Early severe toxicities after capecitabine intake: possible implication of a cytidine deaminase extensive metabolizer profile

Correlation of <i>CDA, ERCC1</i>, and <i>XPD</i> Polymorphisms with Response and Survival in Gemcitabine/Cisplatin–Treated Advanced Non–Small Cell Lung Cancer Patients

Carmelo Tibaldi, Elisa Giovannetti, Enrico Vasile et al. · Clinical Cancer Research · 2008 · 208 citations

Medicine, Molecular Genetics, Oncology +17

Pharmacokinetics of Gemcitabine in Japanese Cancer Patients: The Impact of a Cytidine Deaminase Polymorphism

Emiko Sugiyama, Nahoko Kaniwa, Su-Ryang Kim et al. · Journal of Clinical Oncology · 2006 · 187 citations

Medicine, Oncology, Pharmacology +16

Gemcitabine Pharmacogenomics: Cytidine Deaminase and Deoxycytidylate Deaminase Gene Resequencing and Functional Genomics

Judith A Gilbert, Oreste E. Salavaggione, Yuan Ji et al. · Clinical Cancer Research · 2006 · 156 citations

Medicine, Genetics, Oncology +16

A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity

Li-Jie Yue, Yutaka Saikawa, Kazuhisa Ota et al. · Pharmacogenetics · 2003 · 108 citations

Medicine, Genetics, Molecular Genetics +9

Severe Drug Toxicity Associated with a Single-Nucleotide Polymorphism of the <i>Cytidine Deaminase</i> Gene in a Japanese Cancer Patient Treated with Gemcitabine plus Cisplatin

Kan Yonemori, Hideki Ueno, Takuji Okusaka et al. · Clinical Cancer Research · 2005 · 84 citations · Full text

Medicine, Oncology, Pharmacokinetics +16